Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 31, Number 7—July 2025

Research Letter

Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024

Kaitlin BenedictComments to Author , Alexander Jordan, Jeremy A.W. Gold, Dallas J. Smith, Tom Chiller, Ian Hennessee, Philip M. Polgreen, and Susan E. Beekmann
Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K. Benedict, A. Jordan, J.A.W. Gold, D.J. Smith, T. Chiller, I. Hennessee); University of Iowa Carver College of Medicine, Iowa City, Iowa, USA (P.M. Polgreen, S.E. Beekmann)

Main Article

Table 2

Cryptococcal antigen blood test use for patients with advanced HIV, reported by 215 US infectious disease providers in Emerging Infections Network survey of screening for cryptococcal antigenemia, United States, 2024*

Characteristic CD4 count, no. (%)†
<100 cells/mm3 <200 cells/mm3
Newly initiating ART n = 171 n = 166
Never 23 (13) 34 (20)
Rarely 22 (13) 43 (26)
Sometimes 19 (11) 34 (20)
Often 27 (16) 19 (11)
Always
80 (47)
36 (22)
Reinitiating ART n = 168 n = 160
Never 35 (21) 48 (30)
Rarely 28 (17) 44 (28)
Sometimes 47 (28) 41 (26)
Often 20 (12) 13 (8)
Always
38 (23)
14 (9)
Experiencing ART failure n = 166 n = 161
Never 44 (27) 57 (35)
Rarely 37 (22) 47 (29)
Sometimes 51 (31) 44 (27)
Often 20 (12) 8 (5)
Always
14 (8)
5 (3)
Seriously ill‡ n = 176 n = 168
Never 8 (5) 11 (7)
Rarely 5 (3) 16 (10)
Sometimes 27 (15) 27 (16)
Often 43 (24) 38 (23)
Always 93 (53) 76 (45)

*ART, antiretroviral therapy. †Among respondents who answered each question. ‡Regardless of ART status.

Main Article

Page created: May 15, 2025
Page updated: June 25, 2025
Page reviewed: June 25, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external